Gannet BioChem Achieves Science Based Targets initiative (SBTi) Validation for Near-Term Climate Commitments
Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today